Results 81 to 90 of about 92,137 (193)
Air Everywhere: A Rare Post-ERCP Syndrome of Acute Pancreatitis, Pneumothorax, and Multicompartment Air Leak without Perforation. [PDF]
Hazzouri AA +6 more
europepmc +1 more source
ABSTRACT Chronic obstructive pulmonary disease (COPD) remains the third leading cause of death worldwide, and conventional bronchodilator‐based therapies have limited efficacy in preventing exacerbations and disease progression. The 2024–2026 period represents a historic inflection point: three mechanistically distinct agents received Food and Drug ...
Naoya Fujino, Hisatoshi Sugiura
wiley +1 more source
Prediction of Lobar Emphysema Progression with a CT-Based Foundational Model. [PDF]
Curiale AH +2 more
europepmc +1 more source
Rapidly Progressive Subcutaneous Emphysema and Sequential Bilateral Pneumothoraces Following Pediatric Tracheocutaneous Fistula Closure: A Postoperative Air-Leak Syndrome Recognized in the Post-anesthesia Care Unit (PACU). [PDF]
Bryant D, Pius A, Choromanski D.
europepmc +1 more source
Chinese Guidelines for the Diagnosis and Surgical Treatment of Adult Obstructive Sleep Apnea (2024)
ABSTRACT Obstructive sleep apnea (OSA) is a common chronic disorder characterized by abnormal breathing during sleeping. OSA can damage various organs throughout the body and is burdensome, both socially and economically. Moreover, as OSA has been increasingly studied in recent years, new evidence‐based guidelines for its diagnosis and surgical ...
Working Group of Guideline for the Diagnosis and Surgical Treatment of Adult OSA +7 more
wiley +1 more source
Sub-Tenon Emphysema From Compressed Air Injury in a Patient With Marfan Syndrome. [PDF]
Wolf AB, Pircher A.
europepmc +1 more source
The study included 108 patients admitted to Peking University Third Hospital from January 2015 to December 2025. The most common surgical combination was wedge resection + wedge resection (44.4%). The mean postoperative hospital stay was 6.55 ± 3.03 days. Severe complications Less than 5%. No 30‐day mortality or unplanned secondary surgery.
Huayu He +12 more
wiley +1 more source
Voice Change Following Third Molar Alveolectomy: A Rare and Preventable Complication. [PDF]
Majcen L +7 more
europepmc +1 more source
ABSTRACT Trastuzumab deruxtecan (T‐DXd) is a third‐generation, HER2‐targeting antibody‐drug conjugate that has been shown to significantly prolong overall survival, compared with standard chemotherapy, when used to treat patients who have “HER2‐low” (HER2 immunohistochemistry [IHC] score 1+; or HER2 IHC 2+ plus in situ hybridization‐negative ...
Andrew Redfern +8 more
wiley +1 more source

